Redsense Medical AB (publ) (NGM:REDS)
7.12
+0.02 (0.28%)
At close: Feb 27, 2025
Redsense Medical AB Revenue
In the year 2024, Redsense Medical AB had annual revenue of 32.63M SEK with 27.85% growth. Redsense Medical AB had revenue of 14.40M in the quarter ending December 31, 2024, with 77.08% growth.
Revenue
32.63M
Revenue Growth
+27.85%
P/S Ratio
3.58
Revenue / Employee
6.53M
Employees
5
Market Cap
116.76M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 32.63M | 7.11M | 27.85% |
Dec 31, 2023 | 25.52M | 8.76M | 52.32% |
Dec 31, 2022 | 16.75M | 410.00K | 2.51% |
Dec 31, 2021 | 16.34M | -757.98K | -4.43% |
Dec 31, 2020 | 17.10M | 2.87M | 20.19% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Swedish Orphan Biovitrum AB | 26.03B |
Getinge AB | 34.76B |
Sectra AB | 3.14B |
Camurus AB | 1.87B |
Medicover AB | 23.97B |
Vitrolife AB | 3.61B |
Bonesupport Holding AB | 898.73M |
Elekta AB | 17.88B |